Delivery Order SPE2DB24D2100-SPE2DB24FBAQQ
Award Date 3/29/24
Potential Completion Date 4/1/24
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,004.96, is for the delivery of Difluprednate 0.05% eye drops in 5 milliliter vials. The contract is a Firm Fixed Price Delivery Order with a completion date of February 27, 2024. The contract is not set aside for any specific business category. Amerisourcebergen Drug Corp is a subsidiary of...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of Difluprednate 0.05% eye drops in 5 milliliter vials, with a ceiling value of $1,555.44 and a performance period through April 29, 2024. The contract is a firm fixed price delivery order, placed under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Difluprednate 0.05% eye drops in a 5ML format. This is a firm fixed-price delivery order with a ceiling value of $6,669.15 and an ultimate completion date of August 8, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency awarded a $1,043.01 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Difluprednate 0.05% eye drops in 5ml quantities. This firm fixed-price contract, which carries an ultimate completion date of July 29, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was made through open competition with no set-aside designation, and performance will be...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at $2,724.55 to Amerisourcebergen Drug Corporation for the supply of 5mL bottles of 0.05% difluprednate eye drops. Performance will occur in Conshohocken, Pennsylvania over one day in late June 2023. Amerisourcebergen Corporation, the parent company of Amerisourcebergen Drug Corporation, will serve as the prime contractor. No subcontractors or set aside designations were indicated. This delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $3,807.19 firm fixed price delivery order is for the provision of Difluprednate 0.05% eye drops, 5 ml. The contract has a completion date of February 28, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The delivery order is for the supply of difluprednate 0.05% eye drops in 5 ml containers, with a ceiling value of $3,965.92 and a completion date of March 8, 2023. The contract was awarded on a full and open competition basis, without any set-aside designation....
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of DIFLUPREDNATE 0.05% eye drops. The $1,549.50 contract has a completion date of May 2, 2023 and does not have a set-aside designation, indicating full and open competition. AmerisourceBergen Drug Corporation is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Difluprednate 0.05% eye drops. The $1,143.36 award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of...
- This federal contract award, valued at $11,601.85, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of Difluprednate 0.05% eye drops in 5 ml bottles. This contract is a delivery order and has a firm fixed price pricing type, with a completion date of May 15, 2023. The contract was awarded on May 12, 2023 and does not have a set-aside designation, indicating open competition....
- SPE2DB24D2100Indefinite Delivery Contract
- SPE2DB24D2100-SPE2DB24FBAQQDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Difluprednate 0.05% eye drops in 5mL volumes. The $1,171.84 contract has an ultimate completion date of April 1, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract with DLA valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this contract.
Generated 6/28/24, 10:11 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 3/29/24 |